Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Pharmaceuticals / Submissions and Approvals
AbbVie Cancer Drug Approved for CDF Coverage in UK
Oct. 12, 2017
UK drug regulators approved venetoclax for coverage through the Cancer Drugs Fund of the National Health Service.
The drug is marketed by AbbVie as Venclyxto.
Venclyxto was approved for treating chronic lymphocytic leukemia in adults.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing